Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Carcinoma: Analysis of 30-Day Morbidity and Mortality

Cripe James; Tseng Jill; Eskander Ramez; Fader Amanda Nickles; Tanner Edward; Bristow Robert

首页> 外文期刊>Annals of surgical oncology >Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Carcinoma: Analysis of 30-Day Morbidity and Mortality

【24h】

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Carcinoma: Analysis of 30-Day Morbidity and Mortality

机译：复发性卵巢癌的细胞减少手术和高温腹膜内化疗：30天发病率和死亡率分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The aim of this study was to evaluate morbidity and mortality associated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with ovarian, fallopian tube, and primary peritoneal cancer.

机译：这项研究的目的是评估在卵巢癌，输卵管癌和原发性腹膜癌患者中，进行细胞减灭术和高温腹膜内化疗（HIPEC）相关的发病率和死亡率。

著录项

来源
《Annals of surgical oncology》 |2015年第2期|共7页
作者
Cripe James; Tseng Jill; Eskander Ramez; Fader Amanda Nickles; Tanner Edward; Bristow Robert;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类外科学;
关键词
入库时间 2022-08-18 10:14:47

相似文献

外文文献
中文文献
专利

1. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Carcinoma: Analysis of 30-Day Morbidity and Mortality [J] . Cripe James, Tseng Jill, Eskander Ramez, Annals of surgical oncology . 2015,第2期

机译：复发性卵巢癌的细胞减少手术和高温腹膜内化疗：30天发病率和死亡率分析
2. Re: "cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: Multi-institutional phase II trial." - Proposal of a clinical trial of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer, the CHORINE study. [J] . AnsaloniL., DeIacoP., FrigerioL. Gynecologic Oncology: An International Journal . 2012,第1期

机译：回复：“细胞减灭术和腹膜内高温化疗作为晚期上皮性卵巢癌的前期治疗：多机构II期临床试验。” -有关CHORINE研究的一项针对晚期卵巢癌的细胞减灭术和腹膜高温化疗的临床试验的建议。
3. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial and recurrent ovarian carcinoma: a single center experience [J] . Maja J. Pavlov, Miljan S. Ceranic, Stojan M. Latincic, International journal of hyperthermia: The official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group . 2018,第5期

机译：细胞还原手术和高温腹腔内化学疗法治疗晚期上皮性和复发性卵巢癌：单中心经验
4. Efficacy of Intraperitoneal Perfusion Hyperthermic Chemotheraphy(CHIP)With Cisplatin Combined With Intraveuous Chemotherapy for Patients With Advanced Gastrointestinal Carcinoma [C] . The 3rd Asian congress on hyperthermic oncology and the 9th Chineses symposium on hyperthermic oncology . 2002

机译：腹腔灌注热化学疗法（CHIP）联合顺铂联合静脉化疗治疗晚期胃肠道癌的疗效
5. The Evolution of Hyperthermic Intraperitoneal Chemotherapy in The Setting of Advanced Ovarian Cancer [D] . Quindlen, Kevin J. 2019

机译：高温腹膜内化疗的演变在晚期卵巢癌的环境中
6. Predictors of morbidity and mortality in patients submitted to cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for ovarian carcinomatosis: a multicenter study [O] . Antonio Macrì, Fabio Accarpio, Vincenzo Arcoraci, 2021

机译：患者的发病率和死亡率的预测因素加上卵巢癌患者的患者中腹膜内化疗：多中心研究
7. 269 A prospective study of factors predicting morbidity and mortality in cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for advanced epithelial ovarian malignancy [O] . VK Ahuja, S Somashekar, K Ashwin, 2019

机译：269预测细胞导致手术和高温腹膜内化疗预测发病率和死亡率的因素的前瞻性研究，用于晚期上皮性卵巢恶性肿瘤

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Recurrent Ovarian Carcinoma: Analysis of 30-Day Morbidity and Mortality

摘要

著录项

相似文献

相关主题

期刊订阅